acetylcysteine has been researched along with cardiovascular agents in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Collis, CS; Davies, MJ; Rice-Evans, C | 1 |
Benedict, CR; Katagiri, T; Pakala, R; Watanabe, T | 1 |
Baumann, J; Bogár, L; Falusi, B; Gál, J; Ghosh, S; Roth, E | 1 |
Chen, N; Ko, M | 1 |
Kozik, A; Rapala-Kozik, M; Zawrotniak, M | 1 |
Chiba, J; Hasegawa, T; Hirota-Takahata, Y; Ishimoto, Y; Iwadate, Y; Kizuka, M; Kobayashi, H; Kurosawa, E; Tanaka, M | 1 |
Lopes, LR; Maltês, S | 1 |
1 review(s) available for acetylcysteine and cardiovascular agents
Article | Year |
---|---|
New perspectives in the pharmacological treatment of hypertrophic cardiomyopathy.
Topics: Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Cardiovascular Agents; Diltiazem; Genetic Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocytes, Cardiac; Sodium Channel Blockers | 2020 |
6 other study(ies) available for acetylcysteine and cardiovascular agents
Article | Year |
---|---|
Comparison of N-methyl hexanoylhydroxamic acid, a novel antioxidant, with desferrioxamine and N-acetyl cysteine against reperfusion-induced dysfunctions in isolated rat heart.
Topics: Acetylcysteine; Animals; Antioxidants; Cardiovascular Agents; Deferoxamine; Heart; Heart Rate; Hydroxamic Acids; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Perfusion; Rats; Rats, Wistar; Ventricular Function, Left; Ventricular Pressure | 1993 |
Antioxidant N-acetylcysteine inhibits vasoactive agents-potentiated mitogenic effect of mildly oxidized LDL on vascular smooth muscle cells.
Topics: Acetylcysteine; Animals; Antioxidants; Cardiovascular Agents; Cells, Cultured; DNA; Humans; Lipoproteins, LDL; Male; Mitogens; Muscle, Smooth, Vascular; Rabbits | 2002 |
[Hemodynamic effects of N-acetylcysteine and ischemic preconditioning in a liver ischemia-reperfusion model].
Topics: Acetylcysteine; Animals; Cardiovascular Agents; Disease Models, Animal; Dogs; Hemodynamics; Ischemic Preconditioning; Liver; Reperfusion Injury | 2008 |
Schisandrin B-induced glutathione antioxidant response and cardioprotection are mediated by reactive oxidant species production in rat hearts.
Topics: Acetylcysteine; alpha-Tocopherol; Animals; Antioxidants; Cardiovascular Agents; Cyclooctanes; Cytochrome P-450 Enzyme System; Drugs, Chinese Herbal; Female; Glutathione; Lignans; Microsomes; Mitochondria; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; NADP; Oxidation-Reduction; Phytotherapy; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Schisandra | 2010 |
Selected mucolytic, anti-inflammatory and cardiovascular drugs change the ability of neutrophils to form extracellular traps (NETs).
Topics: Acetylcysteine; Anti-Inflammatory Agents; Cardiovascular Agents; Cell Survival; Clemastine; Dose-Response Relationship, Drug; Ethamsylate; Extracellular Traps; Healthy Volunteers; Humans; Hydrogen Peroxide; Ketoprofen; NADPH Oxidases; Neutrophils; Phagocytosis; Reactive Oxygen Species | 2015 |
Vestaines, novel vasoactive compounds, isolated from Streptomyces sp. SANK 63697.
Topics: Acetylcysteine; Cardiovascular Agents; Coculture Techniques; Endothelial Cells; Fibroblasts; Humans; Molecular Structure; Quaternary Ammonium Compounds; Streptomyces | 2017 |